BIOWEG
PrivateLast Round
Grant
Sep 10, 2026
Est. Valuation
$95M
Total Funding Raised
$40.11M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BIOWEG operates in Energy & Sustainability and is based in Quakenbrück. Its latest recorded funding round was a Grant round in September 2026.
BIOWEG is a biotechnology company that produces high-performance, bio-based, and biodegradable ingredients to replace microplastics and fossil-based polymers for the cosmetics, personal care, and agriculture industries.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials, Circular Economy, Clean Manufacturing, Fashion & Beauty
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIOWEG Comparables
Compare BIOWEG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Naturbeads | 89% | |
| Cellugy | 86% | |
| Lignopure | 77% |
For institutional investors. Book with your work email.
BIOWEG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 10, 2026 | ||||
| Series A | Sep 10, 2026 | ||||
| Grant | Dec 22, 2025 | ||||
| Accelerator | Feb 10, 2022 | ||||
| VC Round | Jan 6, 2022 | ||||
Grant | Jan 6, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BIOWEG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| RootCamp | Accelerator |
| NBank Capital | Series A |
| Rabo Ventures | Series A |
| BonVenture | Series A |
| European Union | Grant |
| European Innovation Council Fund | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2026
Received $12M from the European Union.
- Aug 12, 2026
Launched RheoWeg, a rheology modifier for cosmetics and chemicals.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_facilitiesSep 22, 2026
Bioweg begins construction of Europe’s largest bacterial cellulose production plant in Germany in Q4 '26, with annual capacity of up to 10,000 tonnes, an allocation of around 60% of its total funding, and first commercial volumes expected in 2028.
- receives_financingSep 22, 2026
Bioweg received financing of $2.3M in equity on Sep 22nd '26.
- receives_financingSep 14, 2026
Bioweg receives $34.8M in Series A financing, combining Rabo equity with a €10.3m NRW-linked grant to support a capital-intensive bacterial-cellulose plant, as reported on Sep 14th '26.
- receives_financingSep 14, 2026
Bioweg receives reported $11.9M financing alongside a €14 million Series A extension from Rabobank Ventures and €10.3 million in EU funding under Produktives.NRW for a planned bacterial-cellulose plant in North Rhine-Westphalia.
- receives_financingSep 12, 2026
Bioweg received financing of $40.6M in funding on Sep 12th '26.
For institutional investors. Book with your work email.
BIOWEG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BIOWEG's valuation, stock price, and market status.
Is BIOWEG a public or private company?
BIOWEG is a private company.
What is the current stock price of BIOWEG?
BIOWEG is a private company, so its shares have no public market price. Caplight tracks BIOWEG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BIOWEG worth (valuation)?
BIOWEG's valuation is estimated at $95.0M based on funding round data.
Can I buy BIOWEG stock?
BIOWEG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BIOWEG's last funding round?
BIOWEG's most recent funding round was Grant on September 10, 2026.
Who are the main investors in BIOWEG?
Key investors in BIOWEG include EIC Fund, Axeleo Capital.
Will BIOWEG IPO soon?
No public IPO plans have been announced for BIOWEG.
How can I track BIOWEG secondary market activity?
Caplight tracks bids, offers, and trades in BIOWEG's shares on secondary markets.